Delivery Order SPE2DE21D7020-SPE2D626F1471
- Not listed
- The Defense Health Agency's Medical Supply Chain has awarded a delivery order to Boston Scientific Corp for agent drug-coated balloons, with a ceiling value of approximately $19.9K and an ultimate completion date of September 22, 2025. This fixed-price contract with economic price adjustment provisions was awarded on September 15, 2025, with no set-aside designation, allowing Boston Scientific to compete openly in the federal marketplace. The work will be performed at Boston Scientific's...
- The Defense Health Agency's Medical Supply Chain awarded a delivery order valued at $8,714.55 to Boston Scientific Corp for drug-coated balloons, with performance scheduled to conclude by July 25, 2025. This fixed-price delivery order with economic price adjustment represents a competitive contract with no set-aside designation. Boston Scientific, headquartered in Marlborough, Massachusetts, will perform work at its primary facility in the same location. The contract exemplifies the ongoing...
- The Defense Health Agency's Medical Supply Chain awarded a delivery order valued at $26,532.60 to Boston Scientific Corp for agent drug-coated balloon medical devices. The contract, issued on August 18, 2025, carries a fixed-price pricing structure with economic price adjustment provisions and has an ultimate completion date of August 25, 2025. This delivery order represents a continuation of Boston Scientific's role as a key supplier of specialized cardiovascular intervention equipment to...
- The Defense Health Agency's Medical Supply Chain awarded a delivery order valued at $21,014.55 to Boston Scientific Corp for agent drug-coated balloons, with an ultimate completion date of July 30, 2025. This fixed-price contract with economic price adjustment was issued without a set-aside designation, allowing Boston Scientific to compete openly in the federal marketplace. The work will be performed at the company's facility in Marlborough, Massachusetts, where Boston Scientific manufactures...
- The Defense Health Agency's Medical Supply Chain awarded a delivery order valued at $41,639.42 to Boston Scientific Corp for agent drug-coated balloons, with an ultimate completion date of September 22, 2025. This fixed-price contract with economic price adjustment was issued without a set-aside designation, allowing Boston Scientific to compete openly in the federal marketplace. The award leverages Boston Scientific's established capabilities as a major supplier of advanced cardiovascular...
- Boston Scientific Corp, a global medical technology company headquartered in Marlborough, Massachusetts, was awarded a fixed-price delivery order valued at $18,134.55 for agent drug-coated balloons by the Defense Health Agency's Medical Supply Chain on August 8, 2025. The delivery order, which carries an ultimate completion date of August 15, 2025, represents a competitive award with no set-aside designation. The contract employs fixed-price pricing with economic price adjustment mechanisms...
- The Defense Health Agency's Medical Supply Chain awarded a delivery order valued at $6,175 to Boston Scientific Corp on September 24, 2025, for the supply of agent drug-coated balloons. The contract is a fixed-price agreement with economic price adjustment provisions and carries an ultimate completion date of October 1, 2025. Boston Scientific will fulfill this order from its Marlborough, Massachusetts facility, where the company manufactures advanced medical devices. No small business set-aside...
- Boston Scientific Corp, a leading global medical technology company headquartered in Marlborough, Massachusetts, has been awarded a delivery order valued at $18,953.95 for agent drug-coated balloon supplies. The contract, awarded on June 6, 2025, with an ultimate completion date of June 11, 2025, is funded through the Defense Health Agency's Medical Supply Chain division. This fixed-price contract with economic price adjustment represents Boston Scientific's continued role as a critical supplier...
- The Defense Health Agency's Medical Supply Chain awarded Boston Scientific Corp a fixed-price delivery order valued at $7,524.80 for drug-coated balloon medical devices, with an ultimate completion date of August 29, 2025. The contract, which is not set-aside and uses economic price adjustment pricing, will be performed at Boston Scientific's Marlborough, Massachusetts facility. This delivery order represents a discrete procurement under the agency's broader medical device supply chain...
- The Defense Health Agency's Medical Supply Chain awarded a delivery order to Boston Scientific Corp for agent drug-coated balloons with a ceiling value of $6,175. The contract is a fixed-price agreement with economic price adjustment provisions, with an ultimate completion date of August 21, 2025. This delivery order was not set aside for any specific business category and will be performed at Boston Scientific's Marlborough, Massachusetts facility. As a prime contractor, Boston Scientific is...
- SPE2DE21D7020Indefinite Delivery Contract
- SPE2DE21D7020-SPE2D626F1471Delivery Order
The Defense Health Agency's Medical Supply Chain awarded a delivery order valued at $100,752.05 to Boston Scientific Corp for Agent Drug Coated Balloons, with an ultimate completion date of October 21, 2025. This fixed-price contract with economic price adjustment will be performed at Boston Scientific's facility in Marlborough, Massachusetts. The award employs no set-aside designation, allowing the vendor to compete openly in the federal marketplace. As a leading global medical technology company, Boston Scientific supplies the federal government with a comprehensive portfolio of cardiovascular intervention devices, including drug-coated balloons, stents, catheters, and related cardiovascular equipment critical to the Defense Health Agency's medical operations. This delivery order represents one of numerous task orders Boston Scientific has received through the Defense Health Agency's medical supply chain programs. The company's federal contract portfolio demonstrates substantial capacity to deliver specialized medical devices to defense healthcare agencies, with previous awards spanning cardiovascular, interventional, and diagnostic equipment. The drug-coated balloon technology under this award supports minimally invasive interventional procedures and reflects the Defense Health Agency's ongoing procurement of advanced cardiovascular devices to support military medical readiness and veteran healthcare delivery across the federal system.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $100.8k | 10/14/25 |